Brendan Scientific (US) launches laboratory software:
This article was originally published in Clinica
Executive Summary
Brendan Scientific (US) has launched StatLIA, a laboratory software system. The company says the package connects to all immunoassay instruments and gives QC/QA, data reduction and data management to CLIA requirements - including method and calibration evaluation, instrument performance and lot-to-lot variation. Brendan says the software can cut lab costs by 15% by enabling operators to streamline their procedures.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.